VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
semaglutide우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42610056

Serum GDF3 is Associated with Visceral Obesity, Insulin Resistance, and Inflammation in Non-Diabetic Adults: A Cross-Sectional Study with an Interventional Component.

Serum GDF3 is Associated with Visceral Obesity, Insulin Resistance, and Inflammation in Non-Diabetic Adults: A Cross-Sectional Study with an Interventional Component.

저자
Zhaozhi Li, Jiaoyang Li, Yun Ouyang, Liyan Jiang, Zhezhen Liao, Li Ran
저널
Diabetes, metabolic syndrome and obesity : targets and therapy
공개일
2026
연구 유형
기타
DOI
10.2147/DMSO.S609998

문헌 요약

Growth differentiation factor 3 (GDF3), a TGFβ superfamily cytokine, has been linked to visceral adipose proliferation and adiposity in animal studies. However, the relationship between circulating GDF3 levels and visceral adiposity in humans remains unclear. This study aimed to assess the potential of serum GDF3 as a biomarker for visceral obesity. This…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기